Skandinaviska Enskilda Banken Ab (Publ) Astrazeneca PLC Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.5 Billion
- Q3 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Astrazeneca PLC stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 88,222 shares of AZN stock, worth $5.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
88,222
Previous 88,222
-0.0%
Holding current value
$5.9 Million
Previous $6.88 Million
0.09%
% of portfolio
0.03%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,354Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.21 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.81 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.49 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.46 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $207B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...